Lazzeri Elena, Ronconi Elisa, Angelotti Maria Lucia, Peired Anna, Mazzinghi Benedetta, Becherucci Francesca, Conti Sara, Sansavini Giulia, Sisti Alessandro, Ravaglia Fiammetta, Lombardi Duccio, Provenzano Aldesia, Manonelles Anna, Cruzado Josep M, Giglio Sabrina, Roperto Rosa Maria, Materassi Marco, Lasagni Laura, Romagnani Paola
Excellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE) and
Excellence Centre for Research, Transfer and High Education for the Development of DE NOVO Therapies (DENOTHE) and Department of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy;
J Am Soc Nephrol. 2015 Aug;26(8):1961-74. doi: 10.1681/ASN.2014010057. Epub 2015 Jan 7.
The critical role of genetic and epigenetic factors in the pathogenesis of kidney disorders is gradually becoming clear, and the need for disease models that recapitulate human kidney disorders in a personalized manner is paramount. In this study, we describe a method to select and amplify renal progenitor cultures from the urine of patients with kidney disorders. Urine-derived human renal progenitors exhibited phenotype and functional properties identical to those purified from kidney tissue, including the capacity to differentiate into tubular cells and podocytes, as demonstrated by confocal microscopy, Western blot analysis of podocyte-specific proteins, and scanning electron microscopy. Lineage tracing studies performed with conditional transgenic mice, in which podocytes are irreversibly tagged upon tamoxifen treatment (NPHS2.iCreER;mT/mG), that were subjected to doxorubicin nephropathy demonstrated that renal progenitors are the only urinary cell population that can be amplified in long-term culture. To validate the use of these cells for personalized modeling of kidney disorders, renal progenitors were obtained from (1) the urine of children with nephrotic syndrome and carrying potentially pathogenic mutations in genes encoding for podocyte proteins and (2) the urine of children without genetic alterations, as validated by next-generation sequencing. Renal progenitors obtained from patients carrying pathogenic mutations generated podocytes that exhibited an abnormal cytoskeleton structure and functional abnormalities compared with those obtained from patients with proteinuria but without genetic mutations. The results of this study demonstrate that urine-derived patient-specific renal progenitor cultures may be an innovative research tool for modeling of genetic kidney disorders.
遗传和表观遗传因素在肾脏疾病发病机制中的关键作用正逐渐明晰,而以个性化方式重现人类肾脏疾病的疾病模型的需求至关重要。在本研究中,我们描述了一种从肾脏疾病患者尿液中选择并扩增肾祖细胞培养物的方法。尿液来源的人类肾祖细胞表现出与从肾脏组织中纯化的细胞相同的表型和功能特性,包括分化为肾小管细胞和足细胞的能力,这通过共聚焦显微镜、足细胞特异性蛋白的蛋白质印迹分析以及扫描电子显微镜得以证实。对经多柔比星肾病处理的条件性转基因小鼠(其中在他莫昔芬处理后足细胞被不可逆标记,即NPHS2.iCreER;mT/mG)进行的谱系追踪研究表明,肾祖细胞是唯一能够在长期培养中扩增的尿液细胞群体。为了验证这些细胞用于肾脏疾病个性化建模的用途,从以下两类儿童的尿液中获取肾祖细胞:(1)患有肾病综合征且在编码足细胞蛋白的基因中携带潜在致病突变的儿童;(2)经下一代测序验证无基因改变的儿童。与从蛋白尿但无基因突变的患者获得的足细胞相比,从携带致病突变的患者获得的肾祖细胞产生的足细胞表现出异常的细胞骨架结构和功能异常。本研究结果表明,尿液来源的患者特异性肾祖细胞培养物可能是用于遗传性肾脏疾病建模的一种创新研究工具。